CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Methylene Blue +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05162417
NCT05162417N/ACompleted

Efficacy of Some Different Photosensitizers in Photodynamic Inactivation of Periodontal Pathogens:A Randomized Clinical Trial

University of Sulaimani·interventional·Posted Dec 17, 2021·Updated Nov 29, 2023

In Brief

A clinical study evaluating Methylene Blue and Toluidine Blue O for Periodontal Diseases and Periodontal Pocket. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Dental biofilm is a primary etiological factor for periodontal diseases.(1) The bacterial biofilm would induce recruitment of leucocytes, neutrophils, and T lymphocytes and the secretion of antibodies, lipopolysaccharides, and chemical inflammatory mediators such as cytokines and chemokines.(2) Thus, periodontal diseases can cause tissue destruction and results in deterioration of clinical parameters measures such as periodontal pockets depth, clinical attachment loss, bleeding on probing, bone destruction, and resulting ultimately in tooth loss.(3)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIraq
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 17, 2021
Enrollment StartNov 15, 2021
Primary CompletionNov 1, 2022
Study CompletionApr 1, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 4.5 years ago

Interventions

Methylene Blueother

1mg/ml of Methylene as a solution will be used two times, first immediately after scaling and root planning, second after two weeks of the first treatment.

Toluidine Blue Oother

1mg/ml of Toluidine blue o as a solution will be used two times, first immediately after scaling and root planning, second after two weeks of the first treatment.